Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).

The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of... BACKGROUND: Previous studies comparing intravenous (i.v.) and subcutaneous (s.c.) administration of recombinant human erythropoietin (rHuEpo) often did not achieve optimal iron reserve, were restricted to a limited follow-up period (not allowing equilibration) and/or did not exclude the role of other confounding factors. In addition all papers focused on the conversion from i.v. to s.c. METHODS: In this study, 30 equilibrated patients on s.c. rHuEpo were randomized into two groups, one converting to i.v. after 6 months of follow-up and one remaining on s.c. rHuEpo. In both groups rHuEpo was administered three times weekly. Only patients completing a further 6 months follow-up were considered for statistical evaluation. Serum ferritin was targeted at 200 ng/ml and haematocrits between 28 and 36% were pursued. RESULTS: The average haematocrit levels before conversion were 31.9 +/- 1.1% in the conversion group and 31.4 +/- 1.6% at the same time point in the nonconversion group (P = NS). After 6 months haematocrits were 31.5 +/- 0.5% in the conversion group and 31.1 +/- 0.9% in the non-conversion group (P = NS). Ferritin concentration in the conversion group was 219 +/- 49 ng/ml before and 230 +/- 83 ng/ml after the conversion. For the non-conversion group ferritin was 224 +/- 25 ng/ml and 236 +/- 52 ng/ml respectively (P = NS). The weight-standardized average rHuEpo dose per injection remained the same in the conversion group before and after conversion (44.0 +/- 1.8 U/kg/injection vs 45.4 +/- 4.7 U/kg/injection) (P = NS). In the non-conversion group the corresponding rHuEpo doses were 32.9 +/- 4.2 U/kg/injection and 39.6 +/- 7.0 U/kg/injection respectively (P = NS). There were no differences in serum PTH, aluminium, vitamin B12, folic-acid levels, and intake of co-trimoxazole, ACE inhibitors or theophylline. CONCLUSION: No changes in rHuEpo dose were observed after conversion from s.c. to i.v. There were no significant differences between the conversion and non-conversion group. These results are in contrast to some earlier studies suggesting lower rHuEpo requirements in case of s.c. administration. « Previous | Next Article » Table of Contents This Article Nephrol. Dial. Transplant. (1998) 13 (7): 1770-1775. » Abstract Free Full Text (PDF) Free Services Article metrics Alert me when cited Alert me if corrected Alert me if commented Find similar articles Similar articles in Web of Science Similar articles in PubMed Add to my archive Download citation Request Permissions Disclaimer Responses Submit a response No responses published Citing Articles Load citing article information Citing articles via CrossRef Citing articles via Scopus Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by De Schoenmakere, G. Articles by Vanholder, R. Search for related content PubMed PubMed citation Articles by De Schoenmakere, G. Articles by Lameire, N. Articles by Dhondt, A. Articles by Van Loo, A. Articles by Van der Goten, J. Articles by Duym, P. Articles by Vanholder, R. Related Content Load related web page information Share Email this article CiteULike Delicious Facebook Google+ Mendeley Twitter What's this? Search this journal: Advanced » Current Issue December 2015 30 (12) Alert me to new issues For Readers About the journal Advance Access Recent E-Letters ERA EDTA Guidelines Free sample issue We are mobile – find out more NDT and CKJ app ndt Newsletters Supplements Editors Editor-in-Chief C Zoccali View full editorial board Published on Behalf of For Authors Instructions to authors Online submission instructions Submit a manuscript Self archiving policy Open access options for authors - visit Oxford Open WhsSvhnOkaAwYG81FJCYgwG7z1LnIP2F true Looking for your next opportunity? Looking for jobs... var jQuery_1_11; if ((typeof jQuery != 'undefined') && (jQuery.fn.jquery == "1.11.3")) { jQuery_1_11 = jQuery.noConflict(true); } Alerting Services Email table of contents Email Advance Access CiteTrack XML RSS feed PDA Access var taxonomies = ("MED00340"); Most Most Read Common errors in diagnosis and management of urinary tract infection. I: Pathophysiology and diagnostic techniques Drug treatment of isolated systolic hypertension Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Sample size calculations: basic principles and common pitfalls Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial » View all Most Read articles Most Cited Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Arterial stiffening and vascular calcifications in end-stage renal disease Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure » View all Most Cited articles Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department. Online ISSN 1460-2385 - Print ISSN 0931-0509 Copyright © 2015 European Renal Association - European Dialysis and Transplant Assoc Oxford Journals Oxford University Press Site Map Privacy Policy Cookie Policy Legal Notices Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan Academic & Professional books Children's & Schools Books Dictionaries & Reference Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks International Education Unit Law Medicine Music Online Products & Publishing Oxford Bibliographies Online Oxford Dictionaries Online Oxford English Dictionary Oxford Language Dictionaries Online Oxford Scholarship Online Reference Rights and Permissions Resources for Retailers & Wholesalers Resources for the Healthcare Industry Very Short Introductions World's Classics function fnc_onDomLoaded() { var query_context = getQueryContext(); PF_initOIUnderbar(query_context,":QS:default","","JRN"); PF_insertOIUnderbar(0); }; if (window.addEventListener) { window.addEventListener('load', fnc_onDomLoaded, false); } else if (window.attachEvent) { window.attachEvent('onload', fnc_onDomLoaded); } var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); try { var pageTracker = _gat._getTracker("UA-189672-16"); pageTracker._setDomainName(".oxfordjournals.org"); pageTracker._trackPageview(); } catch(err) {} http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nephrology Dialysis Transplantation Oxford University Press

The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).

The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).

Nephrology Dialysis Transplantation , Volume 13 (7) – Jul 1, 1998

Abstract

BACKGROUND: Previous studies comparing intravenous (i.v.) and subcutaneous (s.c.) administration of recombinant human erythropoietin (rHuEpo) often did not achieve optimal iron reserve, were restricted to a limited follow-up period (not allowing equilibration) and/or did not exclude the role of other confounding factors. In addition all papers focused on the conversion from i.v. to s.c. METHODS: In this study, 30 equilibrated patients on s.c. rHuEpo were randomized into two groups, one converting to i.v. after 6 months of follow-up and one remaining on s.c. rHuEpo. In both groups rHuEpo was administered three times weekly. Only patients completing a further 6 months follow-up were considered for statistical evaluation. Serum ferritin was targeted at 200 ng/ml and haematocrits between 28 and 36% were pursued. RESULTS: The average haematocrit levels before conversion were 31.9 +/- 1.1% in the conversion group and 31.4 +/- 1.6% at the same time point in the nonconversion group (P = NS). After 6 months haematocrits were 31.5 +/- 0.5% in the conversion group and 31.1 +/- 0.9% in the non-conversion group (P = NS). Ferritin concentration in the conversion group was 219 +/- 49 ng/ml before and 230 +/- 83 ng/ml after the conversion. For the non-conversion group ferritin was 224 +/- 25 ng/ml and 236 +/- 52 ng/ml respectively (P = NS). The weight-standardized average rHuEpo dose per injection remained the same in the conversion group before and after conversion (44.0 +/- 1.8 U/kg/injection vs 45.4 +/- 4.7 U/kg/injection) (P = NS). In the non-conversion group the corresponding rHuEpo doses were 32.9 +/- 4.2 U/kg/injection and 39.6 +/- 7.0 U/kg/injection respectively (P = NS). There were no differences in serum PTH, aluminium, vitamin B12, folic-acid levels, and intake of co-trimoxazole, ACE inhibitors or theophylline. CONCLUSION: No changes in rHuEpo dose were observed after conversion from s.c. to i.v. There were no significant differences between the conversion and non-conversion group. These results are in contrast to some earlier studies suggesting lower rHuEpo requirements in case of s.c. administration. « Previous | Next Article » Table of Contents This Article Nephrol. Dial. Transplant. (1998) 13 (7): 1770-1775. » Abstract Free Full Text (PDF) Free Services Article metrics Alert me when cited Alert me if corrected Alert me if commented Find similar articles Similar articles in Web of Science Similar articles in PubMed Add to my archive Download citation Request Permissions Disclaimer Responses Submit a response No responses published Citing Articles Load citing article information Citing articles via CrossRef Citing articles via Scopus Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by De Schoenmakere, G. Articles by Vanholder, R. Search for related content PubMed PubMed citation Articles by De Schoenmakere, G. Articles by Lameire, N. Articles by Dhondt, A. Articles by Van Loo, A. Articles by Van der Goten, J. Articles by Duym, P. Articles by Vanholder, R. Related Content Load related web page information Share Email this article CiteULike Delicious Facebook Google+ Mendeley Twitter What's this? Search this journal: Advanced » Current Issue December 2015 30 (12) Alert me to new issues For Readers About the journal Advance Access Recent E-Letters ERA EDTA Guidelines Free sample issue We are mobile – find out more NDT and CKJ app ndt Newsletters Supplements Editors Editor-in-Chief C Zoccali View full editorial board Published on Behalf of For Authors Instructions to authors Online submission instructions Submit a manuscript Self archiving policy Open access options for authors - visit Oxford Open WhsSvhnOkaAwYG81FJCYgwG7z1LnIP2F true Looking for your next opportunity? Looking for jobs... var jQuery_1_11; if ((typeof jQuery != 'undefined') && (jQuery.fn.jquery == "1.11.3")) { jQuery_1_11 = jQuery.noConflict(true); } Alerting Services Email table of contents Email Advance Access CiteTrack XML RSS feed PDA Access var taxonomies = ("MED00340"); Most Most Read Common errors in diagnosis and management of urinary tract infection. I: Pathophysiology and diagnostic techniques Drug treatment of isolated systolic hypertension Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Sample size calculations: basic principles and common pitfalls Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial » View all Most Read articles Most Cited Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Arterial stiffening and vascular calcifications in end-stage renal disease Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure » View all Most Cited articles Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department. Online ISSN 1460-2385 - Print ISSN 0931-0509 Copyright © 2015 European Renal Association - European Dialysis and Transplant Assoc Oxford Journals Oxford University Press Site Map Privacy Policy Cookie Policy Legal Notices Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan Academic & Professional books Children's & Schools Books Dictionaries & Reference Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks International Education Unit Law Medicine Music Online Products & Publishing Oxford Bibliographies Online Oxford Dictionaries Online Oxford English Dictionary Oxford Language Dictionaries Online Oxford Scholarship Online Reference Rights and Permissions Resources for Retailers & Wholesalers Resources for the Healthcare Industry Very Short Introductions World's Classics function fnc_onDomLoaded() { var query_context = getQueryContext(); PF_initOIUnderbar(query_context,":QS:default","","JRN"); PF_insertOIUnderbar(0); }; if (window.addEventListener) { window.addEventListener('load', fnc_onDomLoaded, false); } else if (window.attachEvent) { window.attachEvent('onload', fnc_onDomLoaded); } var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); try { var pageTracker = _gat._getTracker("UA-189672-16"); pageTracker._setDomainName(".oxfordjournals.org"); pageTracker._trackPageview(); } catch(err) {}

Loading next page...
 
/lp/oxford-university-press/the-haematopoietic-effect-of-recombinant-human-erythropoietin-in-UO6HjYjKpk

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
Copyright © 2015 European Renal Association - European Dialysis and Transplant Assoc
ISSN
0931-0509
eISSN
1460-2385
DOI
ndt;13/7/1770
Publisher site
See Article on Publisher Site

Abstract

BACKGROUND: Previous studies comparing intravenous (i.v.) and subcutaneous (s.c.) administration of recombinant human erythropoietin (rHuEpo) often did not achieve optimal iron reserve, were restricted to a limited follow-up period (not allowing equilibration) and/or did not exclude the role of other confounding factors. In addition all papers focused on the conversion from i.v. to s.c. METHODS: In this study, 30 equilibrated patients on s.c. rHuEpo were randomized into two groups, one converting to i.v. after 6 months of follow-up and one remaining on s.c. rHuEpo. In both groups rHuEpo was administered three times weekly. Only patients completing a further 6 months follow-up were considered for statistical evaluation. Serum ferritin was targeted at 200 ng/ml and haematocrits between 28 and 36% were pursued. RESULTS: The average haematocrit levels before conversion were 31.9 +/- 1.1% in the conversion group and 31.4 +/- 1.6% at the same time point in the nonconversion group (P = NS). After 6 months haematocrits were 31.5 +/- 0.5% in the conversion group and 31.1 +/- 0.9% in the non-conversion group (P = NS). Ferritin concentration in the conversion group was 219 +/- 49 ng/ml before and 230 +/- 83 ng/ml after the conversion. For the non-conversion group ferritin was 224 +/- 25 ng/ml and 236 +/- 52 ng/ml respectively (P = NS). The weight-standardized average rHuEpo dose per injection remained the same in the conversion group before and after conversion (44.0 +/- 1.8 U/kg/injection vs 45.4 +/- 4.7 U/kg/injection) (P = NS). In the non-conversion group the corresponding rHuEpo doses were 32.9 +/- 4.2 U/kg/injection and 39.6 +/- 7.0 U/kg/injection respectively (P = NS). There were no differences in serum PTH, aluminium, vitamin B12, folic-acid levels, and intake of co-trimoxazole, ACE inhibitors or theophylline. CONCLUSION: No changes in rHuEpo dose were observed after conversion from s.c. to i.v. There were no significant differences between the conversion and non-conversion group. These results are in contrast to some earlier studies suggesting lower rHuEpo requirements in case of s.c. administration. « Previous | Next Article » Table of Contents This Article Nephrol. Dial. Transplant. (1998) 13 (7): 1770-1775. » Abstract Free Full Text (PDF) Free Services Article metrics Alert me when cited Alert me if corrected Alert me if commented Find similar articles Similar articles in Web of Science Similar articles in PubMed Add to my archive Download citation Request Permissions Disclaimer Responses Submit a response No responses published Citing Articles Load citing article information Citing articles via CrossRef Citing articles via Scopus Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by De Schoenmakere, G. Articles by Vanholder, R. Search for related content PubMed PubMed citation Articles by De Schoenmakere, G. Articles by Lameire, N. Articles by Dhondt, A. Articles by Van Loo, A. Articles by Van der Goten, J. Articles by Duym, P. Articles by Vanholder, R. Related Content Load related web page information Share Email this article CiteULike Delicious Facebook Google+ Mendeley Twitter What's this? Search this journal: Advanced » Current Issue December 2015 30 (12) Alert me to new issues For Readers About the journal Advance Access Recent E-Letters ERA EDTA Guidelines Free sample issue We are mobile – find out more NDT and CKJ app ndt Newsletters Supplements Editors Editor-in-Chief C Zoccali View full editorial board Published on Behalf of For Authors Instructions to authors Online submission instructions Submit a manuscript Self archiving policy Open access options for authors - visit Oxford Open WhsSvhnOkaAwYG81FJCYgwG7z1LnIP2F true Looking for your next opportunity? Looking for jobs... var jQuery_1_11; if ((typeof jQuery != 'undefined') && (jQuery.fn.jquery == "1.11.3")) { jQuery_1_11 = jQuery.noConflict(true); } Alerting Services Email table of contents Email Advance Access CiteTrack XML RSS feed PDA Access var taxonomies = ("MED00340"); Most Most Read Common errors in diagnosis and management of urinary tract infection. I: Pathophysiology and diagnostic techniques Drug treatment of isolated systolic hypertension Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD? Sample size calculations: basic principles and common pitfalls Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial » View all Most Read articles Most Cited Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Arterial stiffening and vascular calcifications in end-stage renal disease Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure » View all Most Cited articles Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department. Online ISSN 1460-2385 - Print ISSN 0931-0509 Copyright © 2015 European Renal Association - European Dialysis and Transplant Assoc Oxford Journals Oxford University Press Site Map Privacy Policy Cookie Policy Legal Notices Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan Academic & Professional books Children's & Schools Books Dictionaries & Reference Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks International Education Unit Law Medicine Music Online Products & Publishing Oxford Bibliographies Online Oxford Dictionaries Online Oxford English Dictionary Oxford Language Dictionaries Online Oxford Scholarship Online Reference Rights and Permissions Resources for Retailers & Wholesalers Resources for the Healthcare Industry Very Short Introductions World's Classics function fnc_onDomLoaded() { var query_context = getQueryContext(); PF_initOIUnderbar(query_context,":QS:default","","JRN"); PF_insertOIUnderbar(0); }; if (window.addEventListener) { window.addEventListener('load', fnc_onDomLoaded, false); } else if (window.attachEvent) { window.attachEvent('onload', fnc_onDomLoaded); } var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); try { var pageTracker = _gat._getTracker("UA-189672-16"); pageTracker._setDomainName(".oxfordjournals.org"); pageTracker._trackPageview(); } catch(err) {}

Journal

Nephrology Dialysis TransplantationOxford University Press

Published: Jul 1, 1998

There are no references for this article.